EBITDA Margin analysis of Verona Pharma PLC, FY Ratio -10568.56

Loading ...

EBITDA Margin ratio Analysis of Verona Pharma PLC - Deep Dive

Birds's Eye

Fundamental Analysis of Verona Pharma PLC

WARN : Please note that some of the values may not be in base currency

Latest FY EBITDA Margin

Period Ending - Dec-23

-10568.56

Very Poor EBITDA Margin

Period Ending - Dec-22

-14813.76

Very Poor EBITDA Margin

Growth

28.66 %

Trailing Twelve Months EBITDA Margin

Period Ending - Dec-23

-6693.22

Very Poor EBITDA Margin

Most recent Quarter EBITDA Margin

Period Ending - Mar-24

0

Poor EBITDA Margin

EBITDA Margin Analysis of Verona Pharma PLC

Ebitda Margin Ratio of Verona Pharma PLC with value of -6693.22 means that its operating expenses are Higher in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of Verona Pharma PLC with value of 0 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24.
EBITDA Margin Ratio of VRNA rose handsomely by 28.66 % this year.
EBITDA Margin Ratio with value of -136.55 was highest in Year Dec-21 in last Five Years.
EBITDA Margin Ratio with value of -2736792.85 was lowest in Year Dec-20 in last Five Years.
Latest EBITDA Margin Ratio with value of -10568.56 is Greater than Average EBITDA Margin of -985826.97 in last five years.
Ebitda Margin of Verona Pharma PLC is negative because of negative EBITDA in Trailing Twelve Months ended on Mar-24.

Other EBITDA Margin Related Info of VRNA that may interest you.

Verona Pharma PLC Overview

Code	Price	Previous Price	Price Change	Sector
VRNA	15.14	15.56	2.70 %	Biotechnology

Fundamental Analysis Technical Analysis

Defination of EBITDA Margin

EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..

EBITDA Margin Related Ratios

NetProfitMargin

ReturnOnEquity

Tsr Profitability Index


Poor Profitability Stock

FY - Historical EBITDA Margin of Verona Pharma PLC

Period	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
EBITDA Margin	-10568.56	-14813.76	-136.55	-2736792.85	-2166823.12	-1095873.98	0.380
Change	28.66 %	-10748.99 %	100.00 %	-26.30 %	-97.73 %	-288214955.86 %

You are view first 7 Records. Log in to view all 19 in Premium view

FY Chart of EBITDA Margin of Verona Pharma PLC

Note : All Data Generated at the End of Trading Hours (EOD Data)